Filing for a Patent Versus Keeping Your Invention a Trade Secret
Harvard Business Review
NOVEMBER 21, 2013
Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. Budget constraints and the costs for filing a patent force a smart evaluation of your options. These choices are strategic, and a company must think about the broader picture too of the overall intangible assets your company possesses.
Let's personalize your content